Ifeanyichukwu Ifechidere: The Cell-Based Model of Haemostasis
Ifeanyichukwu Ifechidere, Specialist Biomedical Scientist at Sheffield Teaching Hospitals NHS Foundation Trust, shared a post on LinkedIn:
“The Cell-Based Model of Haemostasis.
Why the waterfall cascade is a teaching fiction — and what actually happens on cell surfaces in vivo.
You learned the coagulation cascade in a diagram. Neat arrows.
Sequential activation. Intrinsic pathway meets extrinsic pathway at Factor X. Clean. Logical. Memorable.
The waterfall cascade was never designed to reflect physiology.
It was designed to explain test tube behaviour.
And we have been teaching it as biological truth ever since.
Let’s update the mental model.
What the cascade cannot explain:
- Why patients with severe Factor XII deficiency don’t bleed — despite APTT prolongation
- Why haemophilia A and B cause serious bleeding despite an intact extrinsic pathway
- Why Factor VIIa works therapeutically even in non-haemophiliac bleeding
- Why thrombin generation is far more nuanced than sequential factor activation suggests
The cascade model has no answers for these. The cell-based model does.
The Cell-Based Model — three overlapping phases, three distinct cell surfaces:
- Initiation — on Tissue Factor-bearing cells
Haemostasis begins when vascular injury exposes Tissue Factor.
TF binds circulating Factor VIIa to form the TF:VIIa complex — generating small, insufficient amounts of thrombin.
Not enough to form a clot. Just enough to prime what comes next.
- Amplification — on the platelet surface
That small thrombin burst activates platelets.
Activated platelets amplify the signal — activating Factor V, Factor VIII, and Factor XI on their phospholipid surface.
The coagulation machinery assembles. The stage is set.
- Propagation — on the activated platelet surface
Tenase and prothrombinase complexes assemble at scale.
Factor Xa and Factor Va drive explosive thrombin generation — converting fibrinogen to fibrin, activating FXIII for cross-linking, and producing a stable, robust clot.
Thrombin is the amplifier, the activator, and the architect of the entire system.
Understanding cell-based haemostasis reframes everything:
- Why global assays like TEG and ROTEM reflect physiology better than PT/APTT alone
- Why platelet-poor plasma tells an incomplete haemostatic story
- Why Tissue Factor is the true physiological trigger — not Factor XII contact activation
The cascade is not wrong to teach as an introduction.
But stopping there is a disservice to every scientist and clinician making decisions at the bedside.
Coagulation happens on surfaces. In phases. With cells at the centre of every step.
The test tube taught us the factors.
The cell-based model teaches us the biology.
Think in physiology.
That is what separates a scientist who reports results from one who truly interprets them.
Was the cell-based model taught in your training — or did you discover it later?
Repost to put real haemostasis physiology in front of every scientist and clinician who needs it.”
Find more posts featuring Ifeanyichukwu Ifechidere on Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion